Physician profile
James J Yang
NPI 1467816744
$1,462.63
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $94.20 · 2021: $338 · 2022: $505 · 2023: $425 · 2024: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $525.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $456.48 | 2022-2024 | Linzess, Creon, Viberzi |
| Amgen INC. | $308.62 | 2020-2023 | Repatha |
| Boston Scientific Corporation | $157.14 | 2021 | |
| Alexion Pharmaceuticals, INC. | $134.57 | 2022 | |
| Stryker Corporation | $133.60 | 2023 | Xpress Ent Dilation System, 1788, Spy-Phi System |
| Intuitive Surgical, INC. | $98.22 | 2023 | Da Vinci Surgical System |
| E.R. Squibb & Sons, L.L.C. | $75.00 | 2021 | |
| Amarin Pharma, INC. | $45.70 | 2022 | |
| Phathom Pharmaceuticals, INC. | $25.05 | 2024 | Voquezna |
| Redhill Biopharma INC. | $14.50 | 2021 | |
| Itamar Medical INC | $13.75 | 2024 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.